PHGDH and lymphoma: Importantly, inhibition of PHGDH, either specifically within lymphoma cells using an inducible KO transplantation model or globally using a pharmacological agent, reduces disease progression, highlighting this enzyme as a potentially novel therapeutic target in lymphoma.